RVAC Medicines

RVAC Medicines has built a top-tier talent team in the fields of mRNA, vaccines, and lipid nanoparticle (LNP) technology. We are working hard to develop a series of innovative products to treat infectious diseases and other conditions with unmet needs. Through our efforts, RVAC Medicines will provide additional protection against COVID-19 and SARS-CoV-2 variants for ASEAN countries, as well as innovative therapies for other infectious diseases.